Legislative Activity

This proposed constitutional amendment would eliminate immunity from criminal prosecution for federal officials, including the President, based on their official duties. It also explicitly prohibits the President from issuing a self-pardon for any federal crimes. If ratified, these changes would take effect immediately.

The Ally's Act mandates that certain private health insurance plans must cover auditory implant devices, related supplies, and necessary services for qualifying individuals. This coverage must be comparable to other medical and surgical benefits regarding cost-sharing and treatment limitations. Furthermore, plans cannot deny coverage if a physician or qualified audiologist determines the required hearing items or services are medically necessary. These new requirements take effect for plan years beginning on or after January 1, 2026.

Dillon's Law amends federal guidelines to grant preference points to states that allow trained, non-school personnel to administer epinephrine in schools. This change broadens the definition of who can provide life-saving medication beyond just school employees. The law also updates terminology to cover a wider range of epinephrine delivery systems.

The Stop NOAA Closures Act places a temporary moratorium on the closure or restriction of access to any National Oceanic and Atmospheric Administration (NOAA) facilities. This freeze remains in effect until 180 days after key officials submit a required report to Congress detailing the criteria and process for any future facility changes. After the moratorium lifts, any major facility action will still require a 30-day advance notice and justification report to Congress, except in cases of immediate emergency threatening staff safety.

The Medicaid Breast Cancer Access to Treatment Act expands Medicaid eligibility to cover certain individuals who have had breast or cervical cancer. This legislation also mandates that Medicaid coverage must include breast reconstruction surgery following a medically necessary mastectomy. These changes aim to ensure comprehensive care and remove financial barriers for cancer survivors under the program.

The Microplastics Safety Act mandates the FDA to conduct a comprehensive study on the human health impacts of microplastic exposure through food and water. This research must specifically investigate risks to children's health, endocrine function, cancer, and reproduction. Following the study, the FDA is required to report its findings and recommend necessary legislative or regulatory actions to Congress.

The Medicare Breast Reconstruction Access and Information Act mandates that suppliers performing medically necessary mastectomies must inform patients about their Medicare coverage for post-mastectomy breast reconstruction. This information must be provided and documented in the patient's medical file before the surgery takes place. Failure to comply will result in Medicare withholding payment for the mastectomy procedure.

The Medicare Orthotics and Prosthetics Patient-Centered Care Act aims to enhance protections for Medicare beneficiaries receiving custom braces and artificial limbs. This bill ensures that payment will not be made for certain devices shipped directly to a patient without required training from a qualified practitioner. Additionally, it expands exemptions from competitive bidding for certain providers and clarifies access to replacement custom orthotic devices.

The EARLY Act Reauthorization of 2025 extends the vital Young Women's Breast Health Education and Awareness Requires Learning Young Act of 2009. This legislation ensures the continuation of crucial breast health education and awareness programs. Specifically, it reauthorizes the program, pushing its expiration date from 2026 through the year 2031.

The Healing Partnerships for Survivors Act establishes new federal grants to foster stronger collaborations between health providers, behavioral health programs, disability services, and sexual assault organizations. These funds aim to create coordinated, trauma-informed systems of care that improve comprehensive support for survivors of sexual assault, including adult survivors of childhood sexual abuse. The grants will support activities like direct services, specialized training, and culturally relevant wellness options.

The Accelerating the Development of Advanced Psychology Trainees (ADAPT) Act aims to expand Medicare coverage for mental health services provided by qualified doctoral interns and postdoctoral residents under general supervision. This legislation directs the Secretary of Health and Human Services to establish necessary billing codes for Medicare reimbursement one year after enactment. Furthermore, the Act requires the Secretary to issue guidance to states on removing barriers to covering these trainee services under Medicaid and CHIP programs.

The Cosmetic Supply Chain Transparency Act of 2025 enhances cosmetic regulation by requiring detailed ingredient and supply chain information sharing between brand owners and suppliers. This law mandates the FDA to create a public list of harmful, nonfunctional chemical traces that suppliers must eventually test for and certify. Importantly, this federal legislation preserves the right of states to enact stricter ingredient or transparency rules than those established here.

The Cosmetic Safety for Communities of Color and Professional Salon Workers Act of 2025 aims to enhance cosmetic safety through targeted research into health disparities affecting communities of color and salon workers. The bill mandates improved access to safety data sheets in multiple languages for professional products and establishes two new National Resource Centers to empower these communities and workers. Finally, it brings synthetic hair braids under FDA cosmetic regulation, requiring new safety standards and labeling.

The Cosmetic Hazardous Ingredient Right to Know Act of 2025 significantly updates cosmetic regulation by mandating comprehensive ingredient disclosure, especially for fragrances and flavors, on both product labels and brand owner websites. This law requires detailed, machine-readable online ingredient lists and specific hazard warnings on packaging if certain harmful chemicals are present. Importantly, this federal act preserves the authority of states to enact stricter ingredient bans or transparency requirements.

The Asunción Valdivia Heat Illness, Injury, and Fatality Prevention Act of 2025 mandates that employers protect workers from dangerous heat stress by establishing comprehensive safety standards. This Act requires the Secretary of Labor to create evidence-based rules covering engineering controls, administrative procedures, required training, and paid rest breaks to prevent heat-related illness. Furthermore, the law establishes strict enforcement mechanisms, whistleblower protections, and specific timelines for the implementation of these new federal heat protection standards.

The Toxic-Free Beauty Act of 2025 establishes new federal standards for cosmetic safety by banning the intentional addition of specific harmful chemicals, such as formaldehyde and certain parabens, in products sold in the U.S. It also sets maximum allowable limits for certain contaminants like 1,4 dioxane and lead. Importantly, this federal legislation does not preempt stricter state laws regarding cosmetic ingredients. These new requirements will take effect for products shipped interstate starting January 1, 2027.

The Child Care for Working Families Act establishes comprehensive federal programs to ensure access to high-quality, affordable child care and universal preschool for young children. The legislation creates an entitlement program for child care, mandates that provider reimbursement rates cover actual costs and ensure living wages for staff, and establishes free, universal preschool for 3- and 4-year-olds. Additionally, it provides dedicated funding to stabilize childcare providers and extend the operating hours and compensation for Head Start staff.

The Uterine Cancer Study Act of 2025 mandates a comprehensive federal study to investigate the potential link between the use of chemical hair straighteners and the risk of developing uterine cancer. This research must specifically examine disparities in cancer rates among women of color. The study will ultimately recommend whether the FDA should require additional safety testing for these hair products.

The Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025 aims to improve the detection and treatment of uterine fibroids. It mandates federal research to develop evidence-based early detection strategies and establishes grant programs for states to fund screening, education, and intervention services, prioritizing vulnerable populations. Furthermore, the bill allocates funding for research into pain management related to fibroid surgery and other uterine conditions.

This bill, titled the Epstein Files Transparency Act, mandates the Attorney General to release nearly all unclassified Department of Justice records related to Jeffrey Epstein within 30 days of enactment. The legislation strictly limits the justifications for withholding or redacting documents, prohibiting secrecy based on political sensitivity or potential embarrassment. The only permissible redactions involve victim privacy, child sexual abuse material, or narrowly defined threats to active investigations or national security classifications. Upon completion, the Attorney General must submit a detailed report to Congress listing all released and withheld materials, including an unredacted list of all named government officials.